Question

Which institute has approved the emergency use of 2-deoxy-D-Glucose as additive therapy for Covid -19 patients?

• A. Ministry of Health and Family welfare
• B. Indian Council of Medical Research
• C. Drug controller General of India
• D. World Health Organization

Answer 1

The Correct Option is C

The Drug Controller General of India is the regulatory body responsible for approving drugs, vaccines, and other medical interventions in India. In May 2021, the DCGI granted emergency use authorization for 2-deoxy-D-Glucose as an adjunct therapy in moderate to severe COVID-19 cases. This decision was based on the recommendations of the Indian Council of Medical Research (ICMR), which conducted clinical trials and found promising results for the use of 2-DG in COVID-19 treatment.
The other options, such as the Ministry of Health and Family Welfare, Indian Council of Medical Research (ICMR), and World Health Organization (WHO), play significant roles in healthcare and research but are not directly involved in the approval process for specific drugs at the national level in India.